CA2719805A1 - Multifactorial methods for detecting lung disorders - Google Patents
Multifactorial methods for detecting lung disorders Download PDFInfo
- Publication number
- CA2719805A1 CA2719805A1 CA2719805A CA2719805A CA2719805A1 CA 2719805 A1 CA2719805 A1 CA 2719805A1 CA 2719805 A CA2719805 A CA 2719805A CA 2719805 A CA2719805 A CA 2719805A CA 2719805 A1 CA2719805 A1 CA 2719805A1
- Authority
- CA
- Canada
- Prior art keywords
- lung cancer
- relevant
- patient
- cancer
- analyzing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- 208000019693 Lung disease Diseases 0.000 title claims abstract description 27
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 175
- 201000005202 lung cancer Diseases 0.000 claims abstract description 175
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 175
- 230000014509 gene expression Effects 0.000 claims abstract description 95
- 238000003745 diagnosis Methods 0.000 claims abstract description 24
- 206010028980 Neoplasm Diseases 0.000 claims description 63
- 201000011510 cancer Diseases 0.000 claims description 59
- 238000012360 testing method Methods 0.000 claims description 57
- 108090000623 proteins and genes Proteins 0.000 claims description 56
- 238000013276 bronchoscopy Methods 0.000 claims description 35
- 239000008280 blood Substances 0.000 claims description 24
- 210000004369 blood Anatomy 0.000 claims description 24
- 239000000523 sample Substances 0.000 claims description 17
- 108700011259 MicroRNAs Proteins 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 238000004458 analytical method Methods 0.000 claims description 6
- 230000002159 abnormal effect Effects 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 4
- 238000011285 therapeutic regimen Methods 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 3
- 238000011269 treatment regimen Methods 0.000 claims description 2
- 239000000090 biomarker Substances 0.000 abstract description 54
- 230000035945 sensitivity Effects 0.000 abstract description 19
- 238000012549 training Methods 0.000 description 27
- 238000007477 logistic regression Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 230000000391 smoking effect Effects 0.000 description 9
- 238000002405 diagnostic procedure Methods 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 238000002600 positron emission tomography Methods 0.000 description 5
- 208000008771 Lymphadenopathy Diseases 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000018555 lymphatic system disease Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 210000001552 airway epithelial cell Anatomy 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- -1 miR-189 Proteins 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 108091061943 Mir-218 microRNA precursor family Proteins 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 102100030728 Protein disulfide-thiol oxidoreductase Human genes 0.000 description 2
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 238000007435 diagnostic evaluation Methods 0.000 description 2
- 230000001667 episodic effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 208000037841 lung tumor Diseases 0.000 description 2
- 108091071817 miR-128b stem-loop Proteins 0.000 description 2
- 108091073628 miR-181d stem-loop Proteins 0.000 description 2
- 108091040176 miR-218 stem-loop Proteins 0.000 description 2
- 108091087529 miR-500 stem-loop Proteins 0.000 description 2
- 108091036496 miR-500-2 stem-loop Proteins 0.000 description 2
- 102000029752 retinol binding Human genes 0.000 description 2
- 108091000053 retinol binding Proteins 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 108010066066 tumor-associated NADH oxidase Proteins 0.000 description 2
- AOYNUTHNTBLRMT-SLPGGIOYSA-N 2-deoxy-2-fluoro-aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](F)C=O AOYNUTHNTBLRMT-SLPGGIOYSA-N 0.000 description 1
- 241001598984 Bromius obscurus Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010063599 Exposure to chemical pollution Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108091046841 MiR-150 Proteins 0.000 description 1
- 108091093085 MiR-338 Proteins 0.000 description 1
- 108091062140 Mir-223 Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102000054727 Serum Amyloid A Human genes 0.000 description 1
- 108700028909 Serum Amyloid A Proteins 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 108010025220 aspartic acid 2-oxoglutarate-dependent dioxygenase Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000002113 chemopreventative effect Effects 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 238000009110 definitive therapy Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 108091064157 miR-106a stem-loop Proteins 0.000 description 1
- 108091045790 miR-106b stem-loop Proteins 0.000 description 1
- 108091064399 miR-10b stem-loop Proteins 0.000 description 1
- 108091091360 miR-125b stem-loop Proteins 0.000 description 1
- 108091077112 miR-128a stem-loop Proteins 0.000 description 1
- 108091032320 miR-146 stem-loop Proteins 0.000 description 1
- 108091024530 miR-146a stem-loop Proteins 0.000 description 1
- 108091091751 miR-17 stem-loop Proteins 0.000 description 1
- 108091041042 miR-18 stem-loop Proteins 0.000 description 1
- 108091062221 miR-18a stem-loop Proteins 0.000 description 1
- 108091092012 miR-199b stem-loop Proteins 0.000 description 1
- 108091037787 miR-19b stem-loop Proteins 0.000 description 1
- 108091043187 miR-30a stem-loop Proteins 0.000 description 1
- 108091029750 miR-30a-1 stem-loop Proteins 0.000 description 1
- 108091030035 miR-30a-2 stem-loop Proteins 0.000 description 1
- 108091090692 miR-337 stem-loop Proteins 0.000 description 1
- 108091068952 miR-362 stem-loop Proteins 0.000 description 1
- 108091039521 miR-363 stem-loop Proteins 0.000 description 1
- 108091056495 miR-363-1 stem-loop Proteins 0.000 description 1
- 108091025820 miR-363-2 stem-loop Proteins 0.000 description 1
- 108091030670 miR-365 stem-loop Proteins 0.000 description 1
- 108091036688 miR-365-3 stem-loop Proteins 0.000 description 1
- 108091056454 miR-625 stem-loop Proteins 0.000 description 1
- 108091050734 miR-652 stem-loop Proteins 0.000 description 1
- 108091076732 miR-99a stem-loop Proteins 0.000 description 1
- 108091064318 miR-99a-1 stem-loop Proteins 0.000 description 1
- 108091086202 miR-99a-2 stem-loop Proteins 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000013125 spirometry Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 231100000606 suspected carcinogen Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000019505 tobacco product Nutrition 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4043408P | 2008-03-28 | 2008-03-28 | |
| US61/040,434 | 2008-03-28 | ||
| PCT/US2009/038836 WO2009121070A1 (en) | 2008-03-28 | 2009-03-30 | Multifactorial methods for detecting lung disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2719805A1 true CA2719805A1 (en) | 2009-10-01 |
Family
ID=41114359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2719805A Abandoned CA2719805A1 (en) | 2008-03-28 | 2009-03-30 | Multifactorial methods for detecting lung disorders |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20100055689A1 (enExample) |
| EP (1) | EP2268836A4 (enExample) |
| JP (1) | JP2011516046A (enExample) |
| CA (1) | CA2719805A1 (enExample) |
| WO (1) | WO2009121070A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1874962A2 (en) * | 2005-04-14 | 2008-01-09 | The Trustees Of Boston University | Diagnostic for lung disorders using class prediction |
| EP2605018A1 (en) * | 2006-03-09 | 2013-06-19 | The Trustees of the Boston University | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
| CN101990577A (zh) | 2007-09-19 | 2011-03-23 | 波士顿大学理事会 | 鉴定肺病药物开发的新途径 |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| JP6078339B2 (ja) | 2009-05-07 | 2017-02-08 | ベラサイト インコーポレイテッド | 甲状腺状態の診断のための方法および組成物 |
| CN102892897B (zh) * | 2009-12-24 | 2016-08-03 | 复旦大学 | 用于肺癌的微rna表达谱分析的组合物和方法 |
| US10047401B2 (en) | 2012-08-20 | 2018-08-14 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer |
| US10526655B2 (en) | 2013-03-14 | 2020-01-07 | Veracyte, Inc. | Methods for evaluating COPD status |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| WO2016011068A1 (en) | 2014-07-14 | 2016-01-21 | Allegro Diagnostics Corp. | Methods for evaluating lung cancer status |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| EP3770274A1 (en) | 2014-11-05 | 2021-01-27 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| EP3298182A4 (en) * | 2015-05-19 | 2019-01-02 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for diagnosing or detecting lung cancers |
| CN110114680A (zh) * | 2016-05-05 | 2019-08-09 | 佰欧迪塞克斯公司 | 用于诊断肺癌的组合物、方法和试剂盒 |
| US9612243B1 (en) * | 2016-05-31 | 2017-04-04 | Mor-Nuco Enterprises, Inc. | Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease |
| US10927417B2 (en) | 2016-07-08 | 2021-02-23 | Trustees Of Boston University | Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions |
| KR102421109B1 (ko) * | 2016-09-14 | 2022-07-14 | 필립모리스 프로덕츠 에스.에이. | 개인의 생물학적 상태를 예측하기 위한 시스템, 방법 및 유전자 시그니처 |
| US10677800B2 (en) * | 2016-09-14 | 2020-06-09 | University Of Maryland, Baltimore | Biomarkers for diagnosis and prognosis of lung cancer |
| CN116269239B (zh) * | 2023-04-06 | 2025-12-02 | 上海交通大学医学院附属瑞金医院 | 一种双模态复合肿瘤治疗系统 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3640268A (en) * | 1965-10-23 | 1972-02-08 | Hugh J Davis | Method and device for biopsy specimen collecting and handling |
| US4641662A (en) * | 1984-09-28 | 1987-02-10 | Jaicks John R | Endocervical curette system |
| US4800896A (en) * | 1985-11-08 | 1989-01-31 | Jalowayski Alfredo A | Cell sample collector probe |
| US5422273A (en) * | 1993-03-23 | 1995-06-06 | Baal Medical Products, Inc. | Cell collection apparatus |
| US5477863A (en) * | 1993-04-14 | 1995-12-26 | Grant; Michael A. | Collection kit with a sample collector |
| US5440942A (en) * | 1994-02-02 | 1995-08-15 | Hubbard; Stephen H. | Biological sample collecting and holding device |
| US6085907A (en) * | 1998-05-08 | 2000-07-11 | Institute Of Legal Medicine, University Of Bern | Foldable cardboard box for contact-free drying and long-term storage of biological evidence recovered on cotton swabs and forensic evidence collection kit including same |
| US6746846B1 (en) * | 1999-06-30 | 2004-06-08 | Corixa Corporation | Methods for diagnosing lung cancer |
| IL157872A0 (en) * | 2001-03-12 | 2004-03-28 | Monogen Inc | A panel for detecting a generic disease state containing a plurality of probes and using cell-based diagnosis |
| AU2002250285A1 (en) * | 2001-03-14 | 2002-09-24 | Medical College Of Ohio | Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma |
| AU2002343443A1 (en) * | 2001-09-28 | 2003-04-14 | Whitehead Institute For Biomedical Research | Classification of lung carcinomas using gene expression analysis |
| US20040005294A1 (en) * | 2002-02-25 | 2004-01-08 | Ho-Young Lee | IGFBP-3 in the diagnosis and treatment of cancer |
| US8722331B2 (en) * | 2002-03-28 | 2014-05-13 | University Of Toledo | Method for selecting a treatment for non-small cell lung cancer using gene expression profiles |
| US20040063120A1 (en) * | 2002-07-10 | 2004-04-01 | The Regents Of The University Of Michigan | Expression profile of lung cancer |
| WO2004070062A2 (en) * | 2003-02-04 | 2004-08-19 | Wyeth | Compositions and methods for diagnosing and treating cancers |
| US20040241725A1 (en) * | 2003-03-25 | 2004-12-02 | Wenming Xiao | Lung cancer detection |
| WO2005000098A2 (en) * | 2003-06-10 | 2005-01-06 | The Trustees Of Boston University | Detection methods for disorders of the lung |
| WO2005047451A2 (en) * | 2003-11-12 | 2005-05-26 | Trustees Of Boston University | Isolation of nucleic acid from mouth epithelial cells |
| EP1753873A4 (en) * | 2004-03-05 | 2008-11-05 | Ohio Med College | METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF NUCLEIC ACIDS AND ALLELES |
| US7862995B2 (en) * | 2004-12-10 | 2011-01-04 | Targeted Molecular Diagnostics | Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor |
| EP1851334A4 (en) * | 2005-01-21 | 2010-05-26 | Gene Express Inc | DATABASES FOR EVALUATING NUCLEIC ACIDS |
| EP1874962A2 (en) * | 2005-04-14 | 2008-01-09 | The Trustees Of Boston University | Diagnostic for lung disorders using class prediction |
| EP1940860B1 (en) * | 2005-09-02 | 2012-08-08 | The University of Toledo | Methods for identifying biomarkers useful in diagnosis and/or treatment of biological states |
| EP2605018A1 (en) * | 2006-03-09 | 2013-06-19 | The Trustees of the Boston University | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
| CN101990577A (zh) * | 2007-09-19 | 2011-03-23 | 波士顿大学理事会 | 鉴定肺病药物开发的新途径 |
-
2009
- 2009-03-30 WO PCT/US2009/038836 patent/WO2009121070A1/en not_active Ceased
- 2009-03-30 CA CA2719805A patent/CA2719805A1/en not_active Abandoned
- 2009-03-30 US US12/414,555 patent/US20100055689A1/en not_active Abandoned
- 2009-03-30 JP JP2011502136A patent/JP2011516046A/ja not_active Withdrawn
- 2009-03-30 EP EP09724548A patent/EP2268836A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011516046A (ja) | 2011-05-26 |
| EP2268836A1 (en) | 2011-01-05 |
| US20100055689A1 (en) | 2010-03-04 |
| EP2268836A4 (en) | 2011-08-03 |
| WO2009121070A1 (en) | 2009-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100055689A1 (en) | Multifactorial methods for detecting lung disorders | |
| Beane et al. | A prediction model for lung cancer diagnosis that integrates genomic and clinical features | |
| EP3169814B1 (en) | Methods for evaluating lung cancer status | |
| US20170314081A1 (en) | Methods of detecting cancer | |
| US20150080243A1 (en) | Methods and compositions for detecting cancer based on mirna expression profiles | |
| US20150088430A1 (en) | Methods for evaluating lung cancer status | |
| WO2013049152A2 (en) | Methods for evaluating lung cancer status | |
| US12297505B2 (en) | Algorithms for disease diagnostics | |
| CN114807377B (zh) | 膀胱癌预后生存期标志物的应用、评估装置以及计算机可读取介质 | |
| CN116287355A (zh) | 上消化道肿瘤化疗疗效及不良反应的肠道菌群预测模型 | |
| WO2020207685A1 (en) | Method for determining rcc subtypes | |
| EP4303323B1 (en) | A method differentiating benign and malignant tyroid nodules | |
| CN109182520B (zh) | 一种宫颈癌及其癌前病变检测试剂盒及其应用 | |
| WO2017221744A1 (ja) | 肺がん検査用の情報を提供する方法、肺がんの検査方法、肺がんの検査装置、肺がんの検査装置のプログラム及び記録媒体、並びに肺がん検査用のｍｉＲＮＡ測定用キット | |
| TWI626314B (zh) | 評估罹患大腸直腸癌風險的方法 | |
| US20250305051A1 (en) | Systems and methods of diagnosing idiopathic pulmonary fibrosis | |
| EP3717660B1 (en) | Methods for evaluating head and neck cancers | |
| JP2014054198A (ja) | 大腸ガン検出方法、診断用キット及びｄｎａチップ | |
| US20220243276A1 (en) | Methods of detecting cancer | |
| de Abreu et al. | 23P Unraveling predictive transcriptomic signatures of anti-EGFR therapy response in RAS/BRAF wild-type metastatic colorectal cancer | |
| TW201412989A (zh) | 一種以糞便中細胞基因套組偵測大腸直腸癌的方法 | |
| WO2018061143A1 (ja) | 孤発性大腸癌発症可能性の判定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20140402 |